Issue Date: May 21, 2012
Congress is working to combine multiple actions related to drugs into a single bill. First, the legislation aims to authorize the Food & Drug Administration to collect user fees from the drug and medical device industry for five years. Second, it includes several regulatory reform measures related to drug safety and development.
The House of Representatives and Senate are expected to vote on the package this month with the goal of sending a compromise measure . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society